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1991-7902/Copyrightª 2015, AssociatioAbstract Background/purpose: Most Western studies do not recommend interrupting
warfarin therapy or replacing it with heparin prior to tooth extraction if the international
normalized ratio (INR) levels are maintained. However, this issue remains controversial in
Taiwan. The aim of this study was to investigate whether Taiwanese patients who had an
INR within the therapeutic range required cessation of warfarin prior to dental extractions.
Materials and methods: A total of 60 patients on warfarin with INR <4.0 who underwent 207
dental extractions in 70 occasions were divided into two groups. Thirty-two patients were allo-
cated to the control group (warfarin stopped and switched to heparin under hospitalization)
with average preoperative INR (range) from 2.30 (1.32e3.12) brought down to 1.14 (1.04
e1.32), and 28 patients were allocated to the study group (warfarin continued) with an
average preoperative INR of 1.95 (1.06e3.08).
Results: The incidence of postoperative bleeding in the study group was higher (3/33, 9.1%)
than in the control group (3/37, 8.1%), but this difference was not significant. Local hemostasis
with Gelfoam sponge was sufficient in most patients. Postoperative hemorrhage can be suc-
cessfully managed by repacking with Gelfoam impregnated with tranexamic acid powder in
five patients and resuturing in one patient.
Conclusion: The study proved that dental extractions can be performed without interruption
or alteration of warfarin regimen in Taiwanese patients, provided the INR is below 4.0. Agy and Family Dentistry Section, Department of Dentistry, Kaohsiung Chang Gung Memorial Hospital,
aohsiung 833, Taiwan.
cgmh.org.tw, lulujasmine@gmail.com (S.-Y. Lu).
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Extraction in Taiwanese patients on warfarin 353sufficient hemostasis can be obtained using local measures. This approach can save these in-
dividuals from becoming exposed to the risk of thromboembolism and the inconvenience of
bridging anticoagulation with heparin.
Copyright ª 2015, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. All rights reserved.Introduction
It is very common in primary care dental practice to stop
warfarin therapy for a few days prior to oral surgery in
order to limit bleeding problems. It has been assumed that
discontinuing warfarin for a short period presents negligible
risk to the patient; however, stopping warfarin for several
days can lead to a rebound hypercoagulable state and in-
crease the risk of thromboembolic events.1e6 Although the
risk is small, it outweighs the risk of oral bleeding.3e9
Clinically, we have experienced a mortal risk that
occurred in a 68-year-old Taiwanese female with hyper-
tension, diabetes, and a stroke after cessation of warfarin.
She reported being asked to stop warfarin for 5 days prior to
extraction of a mobile premolar. Two days after tooth
extraction, she was sent to the emergency room because of
a sudden onset of chest tightness, cold sweating, dizziness,
and dyspnea. An acute myocardial infarction with total
occlusion of the right coronary artery was diagnosed, and a
percutaneous coronary intervention was performed. Her
physician strongly suggested that warfarin therapy need not
be modified or discontinued for simple single dental
extractions.
Most Western countries do not recommend reducing or
interrupting warfarin therapy, or replacing it with heparin
prior to dental extraction.2e8 Studies have shown that if an
international normalized ratio (INR) is below 4.0, no
marked differences in the incidence or volume of post-
extraction bleeding happen.3e15 The optimal therapeutic
range of anticoagulation therapy varies for different in-
dications and for patients with various characteristics. Both
the British Society for Hematology and the American Col-
lege of Chest Physicians recommend moderate-intensity
anticoagulation (INR 2.0e3.0) for most indications of
warfarin, such as prophylaxis and treatment of venous
thrombosis, pulmonary embolism, and prevention of sys-
temic embolism secondary to valvular heart disease or
atrial fibrillation. The exceptions that require high-
intensity anticoagulation (INR 3.0e4.5) are patients with
mechanical heart-valve prostheses.16e18 Despite both rec-
ommendations originating from clinical trials conducted in
Western people, the same recommendations have been
adopted for anticoagulation therapy in populations of
different ethnic backgrounds. However, they have shown
lower warfarin requirements in Asians (3 mg daily)
compared with Whites (4e6 mg daily), suggesting that
Asians are more sensitive than Whites to the anti-
coagulation effect of warfarin.19e23 A cohort study of Hong
Kong Chinese patients receiving warfarin therapy with INR
>2.4 reported high incidence of major bleeding, and the
INR of 1.8e2.4 appeared to be associated with the lowestincidence of major bleeding or thromboembolic even-
ts.19e22 The efficacious antithrombotic therapy to prevent
stroke in Taiwan recommended maintaining an INR of 2.0 to
3.0; however, it remained underused.24
In Taiwan, whether to maintain, discontinue, or reduce
antithrombotic therapy for dental extraction has long been
debated, and approaches vary between institutions and
doctors. In one case, a cardiac surgeon referred a number
of patients on warfarin to our department for dental
extraction and administered bridging anticoagulation with
heparin under hospitalization. His conventional practice
had been to let individuals stop warfarin several days prior
to extractions and administer bridging anticoagulation with
heparin under hospitalization, to do an INR on the day of
operation, and to proceed if the INR was <1.5 and close to
1.0. The warfarin treatment was reinstated later on the day
following dental extraction. This approach tried to avoid a
residual anticoagulant effect at the time of the procedure,
and dealt with the doctor’s perception of an increased risk
of serious bleeding if warfarin was not interrupted.
Warfarin therapy is problematic with a narrow thera-
peutic index, wide interaction with foods and drugs, a long
half-life of 48e72 hours, and delayed-onset of 76e96 hours
of action after cessation as well as restarting treatment.
Accordingly, patients may have at least 2e3 days of sub-
therapeutic anticoagulation around the time of surgery and
increase the risk of thromboembolic events.4e6,9 If patients
with INR <4 could be treated routinely without altering
their warfarin regimen, then it is possible that most dental
extractions could be done in general practice on the same
day as regular INR blood monitoring. This would be more
convenient, cost-effective, and quicker for the patients,
and would help to reduce hospital waiting lists.
To the best of our knowledge, this is the first retro-
spective study in Taiwan to evaluate the incidence of
postoperative hemorrhage after dental extraction in pa-
tients with warfarin therapy temporarily modified with
heparin, and in patients without interruption of warfarin
therapy.
Materials and methods
The study was approved by the Institutional Review Board
of Chang Gung Memorial Hospital. A total 65 consecutive
patients on warfarin were referred by either general den-
tists or medical practitioners for dental extractions that
were performed by the same qualified dentist (the first
author) at the Family Dentistry Department of Kaohsiung
Chang Gung Memorial Hospital between January 2010 and
June 2014. Data were collected from the chart notes made
at each visit. Investigated items included patient
Table 1 Tooth extractions in the control group of hospitalized patients for bridging anticoagulation with heparin after
cessation of warfarin and the study group of outpatients maintained on continuing warfarin therapy.
Control group (32 cases) Study group (28 cases) P
Sex (male/female) M (17), F (15) M (16), F (12)
Mean age (range, y) 56.7 (37e81) 63.3 (31e88) 0.547
Main indication for warfarin (patient no.) 32 28
Heart valve replacement 31 11
Atrial fibrillation 0 6
CVA/CAD or PAD/DVT 0 8
Liver or heart transplantation 0 3
Mitral valve stenosis 1 0
Prophylatic antibiotic prophylaxis 32 14
Warfarin mean dose (mg) 3.44  1.54 2.84  1.35 0.165
INR mean (prior to extraction) 2.30  0.39 1.95  0.55 0.189
Range 1.32e3.12 1.16e3.08
Reduced after cessation of warfarin 1.14  0.18
No. of tooth extractions (occasions) 130 (37) 77 (33)
No. of simple extractions 110 68
No. of complicated extractions 20 9
Mean no. of teeth extracted per case 3.5 2.3 0.820
Cause of extraction (postoperative hemorrhage)
Periodontitis 52 (2) 30 (2) 0.531
Deep caries or residual roots 74 (1) 46 (1) 0.787
Impaction 4 1 0.594
Postoperative hemorrhage (no. of patients/occasions) 3/37 (8.1%) 3/33 (9.1%) > 0.99*
*The incidence of postoperative bleeding between the study and the control groups indicated no significant difference (P > 0.99).
CAD Z coronary artery disease; CVA Z cerebral vascular accident; DVT Z deep vein thrombosis; PAD Z peripheral arterial disease.
354 S.-Y. Lu et alclinicodemographic factors (sex, age, dental and medical
diseases), warfarin effectiveness (dose and INR levels),
type of tooth extraction (simple or complicated extrac-
tion), and the incidence of postoperative hemorrhage. Any
patient who had an INR >4.0, had combined antiplatelet
therapy or platelet counts <6  104/mm3, had liver disease
affecting postoperative hemorrhage and coagulopathies, or
had withdrawn warfarin therapy by themselves was
excluded from the study. Of the 65 patients, five were
excluded: two because of INR >4 and three because of
interruption of warfarin by the individuals themselves.
A total of 60 patients with INR <4.0 who underwent 207
dental extractions in 70 occasions were divided into two
groups. A convenience sample of 32 consecutive patients on
warfarin for heart-valve replacement referred from a car-
diac surgeon was included in the control group (Tables 1
and 2). The cardiac surgeon arranged for them to stop
taking warfarin and administered bridging anticoagulation
with heparin several days prior to extractions under hos-
pitalization, with mean preoperative INR (range) from a
level of 2.30 (1.32e3.12) brought down to 1.14
(1.04e1.32). After the extractions, they resumed taking
warfarin on the same day. All patients were hospitalized, at
least for 1 week, for observation. The study group was
composed of 28 patients who were using warfarin for heart
valve replacement (11 patients), atrial fibrillation (6 pa-
tients), ischemic cerebrovascular or heart disease (6 pa-
tients), venous thrombosis (2 patients), liver transplant (2
patient), and heart transplant (1 patient). All of them were
dental outpatients and instructed not to alter their
warfarin dose in any way prior to dental extraction.Patients in the study group did not have their INR evaluated
as it had been measured within several days, with an
average preoperative INR (range) of 1.95 (1.06e3.08)
(Tables 1 and 3). Patients with cardiac valvular disease or
organ transplant were administered an appropriate regime
of antibiotic prophylaxis, according to the recommendation
of the American Heart Association.25 All procedures were
planned in liaison with patients’ medical practitioners and
informed consent.
All tooth extractions were performed with minimal in-
vasion, and inflammatory granulation tissue was curetted as
much as possible. Each extraction was carried out under
local anesthesia using 2% (20 mg/mL) lidocaine hydrochlo-
ride with 1/80,000 (12.5 mg/ml) epinephrine. The standard
hemostatic method in each extraction site was packed with
Gelfoam and followed by wound compression with dry
gauze pack.
Suturing was not considered to be normally necessary,
only on a case-by-case basis and depending on the exten-
sion of the trauma. If hemostasis was not achieved after
biting on a gauze swab for 10 minutes, this socket was
recorded as an immediate bleeding, and repacked with
Gelfoam impregnated with tranexamic acid (TXA) powder.
If this failed, sutures were inserted. The patients were
monitored for a further 30 minutes prior to being
discharged.
Patients were given a leaflet outlining the usual post-
extraction instructions and a telephone number (the hos-
pital’s 24-hour on-call emergency hotline) to contact in
case of any serious hemorrhage. Patients who had hemor-
rhage 1 hour after extraction and needed to return to the
Table 2 Tooth extraction in patients for interrupting warfarin therapy and switching to administration of heparin under hospitalization.
INR group No. of
cases
Age (y) Warfarin
(mg)
INR No. of
extractions
(occasions)
No. of
teeth
extracted
No. of teeth
surgically
extracted
Mean no. of
teeth extracted
per case
No. of patients
with postop.
hemorrhage
Before After
<1.5 1 M, 1F 45.5  8.5 2.86  0.35 1.37  0.05 1.10  0.06 2 6 2 3.0 0 (0%)
1.5e1.99 3 M, 3F 63.8  10.9 2.49  1.15 1.85  0.13 1.13  0.02 6 13 0 2.2 1 (17%)
2.0e2.49 9 M, 5 F 56.1  11.2 3.22  1.27 2.26  0.10 1.11  0.08 17 53 10 3.1 2 (12%)
2.5e2.99 3 M, 6 F 55.9  12.7 4.41  1.78 2.69  0.11 1.20  0.31 11 56 8 5.1 0 (0%)
3.0e4.0 1 M, 0 F 55.0  0.00 3.57  0.00 3.12  0.00 1.13  0.00 1 2 0 2.0 0 (0%)
Total 17 M, 15 F 37 130 20 3 (8.1%)
Mean 56.7  12.2 3.44  1.54 2.30  0.39 1.14  0.18 3.5
P P Z 0.847 P Z 0.281 P Z 0.280 P Z 0.970 P > 0.99 P Z 0.743
The incidence of postoperative hemorrhage indicated no significant differences in age (ANOVA, 0.847), warfarin dose (ANOVA, 0.281), INR (ANOVA, before 0.280, after 0.970), or mean
number of teeth extracted (ANOVA, 0.743) and type of extraction (Fisher’s exact test, 1.000).
ANOVA Z analysis of variance; F Z female; INR Z international normalized ratio; M Z male; No. Z number; postop. Z postoperative.
Table 3 Tooth extraction in patients maintained on continuing warfarin therapy.
INR group No. of cases Age (y) Warfarin (mg) INR No. of
extractions
(occasions)
No. of
teeth
extracted
No. of teeth
surgically
extracted
Mean no. of
teeth extracted
per case
No. of patients
with postop.
hemorrhage
<1.5 5 M, 1 F 62.5  11.3 2.10  1.14 1.2  0.11 8 13 1 1.6 1 (12.5%)
1.5e1.99 3 M, 5 F 59.5  15.9 2.79  1.34 1.81  0.09 11 34 4 3.1 1 (9%)
2.0e2.49 4 M, 3 F 66.9  6.2 3.61  1.31 2.18  0.12 7 17 1 2.4 1 (14%)
2.5e2.99 3 M, 2 F 71.4  9.1 3.29  1.12 2.65  0.13 5 10 3 2.0 0 (0%)
3.0e4.0 1 M, 1 F 54.0  5.0 2.22  0.79 3.05  0.04 2 3 0 1.5 0 (0%)
Total 16 M, 12 F 33 77 9 3 (9.1%)
Mean 63.3  12.7 2.84  1.35 1.95  0.55 2.3
P P Z 0.543 P Z 0.395 P Z 0.402 P Z 0.545 P > 0.99
The incidence of postoperative hemorrhage indicated no significant differences in age (ANOVA, 0.543), warfarin dose (ANOVA, 0.395), INR (ANOVA, 0.402), mean number of teeth
extracted (ANOVA, 1.000) and in type of extraction (Fisher’s exact test, 0.545).
ANOVA Z analysis of variance; F Z female; INR Z international normalized ratio; M Z male; No. Z number; Postop. Z postoperative.
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Figure 1 Number of teeth extracted and occasions of extraction. The postoperative hemorrhage was not associated with the
number of tooth extractions. a Immediate postoperative bleeding happened once. b Delayed bleeding happened once.
356 S.-Y. Lu et alhospital were considered cases of delayed bleeding. Pa-
tients who managed to control the bleeding at home were
not included. All patients were reviewed several days
postoperatively to check whether any delayed bleeding
existed, whether pressure was enough to stop bleeding, and
whether professional help was required to deal with such
hemorrhage.
Patients on warfarin therapy were divided into five INR
groups (<1.5, 1.5e1.99, 2.0e2.49, 2.5e2.99, and 3.0e4.0).
The collected data were analyzed using the SPSS-V-19.0
software (SPSS Inc., Chicago, IL, USA). One-way analysis of
variance was used to analyze age and mean number of
extracted teeth in relation to INR. Categorical data such as
extraction type, warfarin mean doses, and the incidence of
postoperative hemorrhage in relation to INR and between
the two groups were analyzed using the Chi square test or
Fisher’s exact test, as appropriate. A value of P < 0.05 was
considered statistically significant.Results
The results of the study, patients’ characteristics, reasons
for taking warfarin, and tooth extractions are summarized
in Table 1. A group of 60 patients on warfarin (27 women
and 33 men, mean age 59.8 years, range 31e88 years)
fulfilling the requirements were enrolled in the study and
divided into two groups. There were no significant differ-
ences between the groups in terms of mean age or number
of teeth extracted. The average daily dose of warfarin and
INR prior to interruption of warfarin in the control group
was higher than that in the study group, but did not show
any statistical difference.
The total number of extractions performed was 207
teeth on 70 occasions, with the control group requiring 130
teeth on 37 occasions (mean 3.5 per occasion, range 1e13)
and the study group 77 teeth on 33 occasions (mean 2.3 per
occasion, range 1e8). Two patients in the control group
who received simple extraction of one to four teeth, and
three patients in the study group who received simple
extraction of two to three teeth had immediatepostoperative bleeding during the 30 minutes that they
were observed. One patient in the control group who
received simple extraction of seven teeth had delayed
oozing from one of sockets in the lower molars on the 2nd
day postoperatively (Fig. 1). The INR levels at the time of
postoperative hemorrhage ranged from 1.21 to 2.15 among
three patients in the study group and below 1.15 in three
patients of the control group. For seven patients with INR
>2.5 in the study group, 13 teeth were extracted in seven
occasions, but postoperative hemorrhage did not occur.
The incidence of postoperative bleeding was higher in the
study group (3/33, 9.1%) than in the control group (3/37,
8.1%), but the difference was not significant (P Z 1.000;
Table 1). The incidence of postoperative hemorrhage in
both groups was not associated with age, dose of warfarin,
each INR category, and number of tooth extractions or type
of extraction (all P > 0.05; Tables 2 and 3). Six cases of
postoperative hemorrhage involved periodontitis or resid-
ual roots that were complicated by either acute inflam-
mation or alveolar abscess.
Local hemostasis with Gelfoam sponge was sufficient in
most patients. Five confirmed cases of postoperative
hemorrhage can be managed by repacking with Gelfoam
impregnated with TXA powder followed by pressure, and
suturing was not necessary. The wounds were sutured only
for five patients undergoing surgical extractions of
impacted teeth with flap elevation and one patient with
immediate postoperative hemorrhage.Discussion
Planning dental extractions for patients on warfarin pre-
sents a dilemma. Alteration of warfarin preoperatively in
order to reduce the risk of serious bleeding following ex-
tractions puts the patient at risk of thromboembolic even-
ts.3e5 The risk is difficult to estimate, but is probably
between 0.02% and 1%.4,5 Stopping warfarin for 2 days
might increase the risk of thromboembolic events.6,7
Wahl4,5 reported that of 526 patients who experienced
575 interruptions in warfarin therapy, only five had serious
Extraction in Taiwanese patients on warfarin 357emboli complications, but four of them died. We once had a
female patient who was rescued from acute myocardial
infarction with total occlusion of the right coronary artery
by percutaneous coronary intervention 2 days after tooth
extraction because her warfarin had been stopped for 5
days prior to the procedure. All these facts indicate that
discontinuing antithrombotic therapy could lead to lethal
thrombosis. Based on the evidence that postextraction
bleeding problems in patients on warfarin are no more se-
vere than those in patients with normal coagulation, it
appears logical to continue the therapeutic levels of
warfarin for dental surgery.
From the results of this study, it is clear that post-
operative hemorrhage is not a problem following dental
extraction on patients whose warfarin had not been
altered, and those who were treated under local anesthesia
on an outpatient basis. None of the patients with immedi-
ate or delayed postoperative bleeding required blood
transfusion or parenteral TXA or reduction of warfarin dose
or administration of vitamin K. Postoperative hemostasis
can be successfully managed by repacking with Gelfoam
plus TXA powder or suturing the sockets, which was safe,
simple, and less troublesome than continuing TXA mouth-
wash for days.26
A number of studies have reported that Iranians and
Asians are more sensitive to warfarin than Westerns.19e22
Most patients in the study needed a lower warfarin
requirement compared with Whites, although the intensity
of the anticoagulation was comparable; moreover, a few
took a very low dosage of warfarin but maintained a high
intensity of anticoagulation level (Tables 1e3). This meant
that warfarin use was complicated by an unpredictable
dose response, and its anticoagulation effect was subject to
wide inter- and intraindividual variability that possibly led
to hemorrhagic or thromboembolic events despite careful
dosage titration.
Based on our findings, the incidence of postoperative
hemorrhage was unrelated to age, each INR category,
number of tooth extractions, and type of extraction. The
postoperative bleeding prevalence (9.1% in the study group
and 8.1% in the control group) was higher than that of most
Western studies (average <5%), but was quite close to the
results of a study conducted in Jordan (12% in the group
without alteration of warfarin, and 8% in the group with
cessation of warfarin and switching to heparin).3e15,23 Our
findings provided additional evidence to the contention
that Chinese and Iranian patients require a lower mainte-
nance dose of warfarin and a lower INR for protection from
thromboembolism, and might be at increased risk of
bleeding at lower INRs.19e22 However, most cases of post-
operative hemorrhage were minimal, and bleeding can be
managed by pressure or repacking and suturing the sockets.
Based on our results, we suggest that INR levels within the
therapeutic range for patients on warfarin should not be
altered prior to dental extraction, provided they have no
history of liver or blood disease or taking any medications
affecting hemostasis. The same target INR range for West-
ern populations needing dental extractions was also the
optimal anticoagulation level for Taiwanese patients. The
impact of racial and ethnic differences on the kinetics of
dose response or on drug efficacy was not well defined, as
few clinical studies took ethnic variation into account.Therefore, frequent INR monitoring was important and
facilitated analysis of ethnic variation among
subpopulations.
The INR levels in six patients with postoperative hem-
orrhage were not markedly high at the time of tooth
extraction. Moreover, all were confirmed after simple
extraction rather than invasive surgical extraction, and
most were accompanied by existing acute inflammation
around the teeth. Many dental studies have reported that
local hemostasis was less successful when acute inflam-
mation was present, which is compatible with our
results.3e6
The heparin in the control group was discontinued for a
minimum of 6 hours preoperatively and resumed 12e24
hours after surgery, along with regular preoperative dosage
of warfarin until INR was back to the optimal therapeutic
level. This required hospitalization for 1 week at least and
careful monitoring; however, this put the patients at risk of
postoperative thromboembolism as warfarin may require
several days to reach the therapeutic levels required.
Heparin administration had an uncontrollable risk factor
and carried a higher degree of complexity and discomfort
for the patients.
Dentists and physicians should collaborate closely when
treating patients on warfarin to make sure that their INR
levels are within the therapeutic range prior to dental
surgery, and then any individual requiring tooth extraction
can be treated on an outpatient basis. Most cases, partic-
ularly for single or simple straightforward extractions,
could be performed on the same day, which can save
valuable time and resources in hospital care.
Today dentists are seeing an increased number of pa-
tients with chronic medical illnesses. Among these patients
are those who are being treated with oral anticoagulants to
prevent venous or arterial thrombosis. Good surgical tech-
niques and local measures to control bleeding must be used
well in all oral surgical procedures, especially in those
receiving continuous oral anticoagulants.Conflicts of interest
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